Protecting patents to ensure supplies

Health Ministry Guidelines News

Protecting patents to ensure supplies
Patent LinkageGeneric Medicines AccessInnovator Drug Patents

CHICAGO, April 9 (Reuters) - Meta Platforms said on ⁠Thursday it is pulling ads from Facebook and Instagram aimed at recruiting new plaintiffs for ongoing litigation accusing it and other social media companies ⁠of designing their platforms to be addictive to young users.

Balancing act: The Health Ministry says the patent linkage guideline emphasises the importance of protecting intellectual property while ensuring timely access to affordable medicines. —AZHAR MAHFOF/The Star PETALING JAYA: The Health Ministry is drafting guidelines to ensure hospitals will have continued access to generic medicines even during legal disputes from the original brand names over patent issues.

Known as the patent linkage guideline, it is also to ensure generic drugs do not infringe on innovator drug patents. It will allow access to generic drugs but at the same time ensure that the patent of innovator drugs is not infringed. This guideline is meant to prevent any problem should there be a court case between the patent holder and the generic drug manufacturer. The guidelines are necessary as Malaysia had ratified the Comp­rehensive and Progressive Agree­ment for Trans-Pacific Part­ner­ship in September 2022. Article 18.53 of the agreement requires members to establish a notification mechanism to patent holders, provide adequate opportunity to seek legal remedies and establish procedures to resolve patent disputes before marketing. According to the ministry in a public consultation document released recently, the guidelines would fulfil Malaysia’s CPTPP commitments, besides safeguarding access to medicines. It also helps in preserving judicial determination of patent disputes and ensuring regulatory neutrality, it said. Malaysia has four-and-a-half years from the date of the agreement coming into force to implement the patent linkage measures. “This provision emphasises the importance of protecting intellectual property in the pharmaceutical industry while ensuring timely access to affordable medicines,” said the ministry’s document. Patent linkage refers to a regulatory mechanism that links the approval of a generic pharmaceutical product to the patent status of the corresponding New Drug Product . “It does not prevent generic entry. It introduces a transparent notification mechanism allowing patent disputes to be resolved through the courts,” the ministry said. Patent linkage will apply to all pharmaceutical product registration applications intended for human use, except for biologics. This includes pharmaceutical products originating from all countries and not limited to countries that are parties to the CPTPP. Patent linkage will only apply to product patents claiming the active pharmaceutical ingredient , formulation, polymorphs, salts, esters, dosage form, dosing regimen; as well as patents claiming approved medical use under the NDP.Patent linkage will not apply during public health emergency; products which requires a compulsory licence under the Patents Act, and those where the rights of the government is authorised under the Patents Act and other urgent national measures. Those applying for patent linkage due to their patent status or with the intention of marketing their products must indicate whether the product is protected by a granted patent in Malaysia . The National Pharmaceutical Regulatory Agency will verify procedural compliance, manage notification and suspension periods, and notify the generic product registration holder when legal proceedings are initiated by PRH NDP, patent owner and patent licensee. However, the NPRA will not determine patent validity, interpret patent scope and decide on patent infringement.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

staronline /  🏆 4. in MY

Patent Linkage Generic Medicines Access Innovator Drug Patents CPTPP Commitments Pharmaceutical Industry Intellectual Property Protection Patent Disputes Resolution Generic Drug Approval Malaysia Patent Linkage

 

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Samsung to launch Galaxy A57 and A37 on April 10; prices start from RM1,899Samsung to launch Galaxy A57 and A37 on April 10; prices start from RM1,899KUALA LUMPUR: Here is a recap of the announcements that made headlines in Corporate Malaysia.
Read more »

Fuel prices April 9-15: Unsubsidised petrol up 40sen, diesel in peninsula up 70senFuel prices April 9-15: Unsubsidised petrol up 40sen, diesel in peninsula up 70senKUALA LUMPUR: Here is a recap of the announcements that made headlines in Corporate Malaysia.
Read more »

Pakistan to host US-Iran ceasefire talks on Friday (April 10)Pakistan to host US-Iran ceasefire talks on Friday (April 10)KUALA LUMPUR: Here is a recap of the announcements that made headlines in Corporate Malaysia.
Read more »

The Music Run Is Back This April With Performances By Dato’ Siti Nurhaliza & Other Amazing ActsThe Music Run Is Back This April With Performances By Dato’ Siti Nurhaliza & Other Amazing ActsA run and a music festival, all in one.
Read more »

Harga Petrol Naik 40 Sen, Diesel Naik 70 Sen & Harga RON 95 Budi Kekal Pada RM1.99 SeliterHarga Petrol Naik 40 Sen, Diesel Naik 70 Sen & Harga RON 95 Budi Kekal Pada RM1.99 SeliterKenaikan harga ini diselaraskan untuk tempoh 9 April 2026 hingga 15 April 2026.
Read more »

Protecting Children: The Reasoning Behind Concealing Their IdentityProtecting Children: The Reasoning Behind Concealing Their IdentityDiscover the reasons why parents, including celebrities like Neelofa and PU Riz, are choosing to conceal their children's faces. Learn about the Islamic concept of the 'ain and how it influences this practice. Understand the importance of expressing gratitude and the appropriate responses to compliments.
Read more »



Render Time: 2026-04-19 10:01:57